✦ LIBER ✦

6615 POSTER Biweekly paclitaxel as second-line treatment in advanced non-small-cell-lung-cancer (NSCLC). A phase II study of the Galician Lung Cancer Group

✍ Scribed by Vázquez-Estévez, S.; Fírvida, J.L.; Grande, C.; Barón, F.; Lázaro, M.; Salgado, M.; Campos, B.; Casal, J.; Pérez, E.; Mel, J.R.

Book ID: 122051483
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 58 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(07)71443-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-588 Biweekly docetaxel and vinorelbine

P-588 Biweekly docetaxel and vinorelbine as second-line treatment in advanced (stage IIIB+ IV) non-small-cell lung cancer (NSCLC). A phase II study of the Galician Lung Cancer Group

✍ Vázquez, S.; Villanueva, M.; Amenedo, M.; Firvida, J.; Lázaro, M.; Del Río, L.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Phase II study of low-dose weekly paclit

Phase II study of low-dose weekly paclitaxel as second-line treatment for advanced non-small cell lung cancer

✍ O. Juan; V. Alberola; A. Rocher; R. Casany; V. Carañana; J.M. Campos; A. Albert; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 347 KB

Gemcitabine plus docetaxel as first-line

Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study

✍ Joaquín Casal; Margarita Amenedo; José Ramón Mel; Luis Miguel Antón; Rubén Rodrí 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 343 KB

Concurrent chemoradiation for stage III

Concurrent chemoradiation for stage III non-small cell lung cancer (NSCLC): A phase II study from the Galician lung cancer group

✍ Casal, J.; Anido, U.; Garcia, N.; Varela, S.; Fírvida, X.; Taboada, B.; Hernánde 📂 Article 📅 2013 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 55 KB

103 POSTER A phase II study of enzastaur

103 POSTER A phase II study of enzastaurin as second- or third-line treatment of non-small cell lung cancer (NSCLC)

✍ Y. Oh; R. Herbst; H. Burris; A. Cleverly; M. Lahn; G. Bepler 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Assessment of tubulin mutations in a pha

Assessment of tubulin mutations in a phase II study of biweekly gemcitabine/paclitaxel (T) in advanced non-small-cell lung cancer (NSCLC)

✍ Rosell, R; O'Brate, A; Sánchez, J; Isla, D; Felip, E; Camps, C; González-Larriba 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB